C. Russell Trenary III
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Start not stated–2024-12-03
-
Start not stated–2024-12-03
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Outlook Therapeutics, Inc. (OTLK) | Former President and Chief Executive Officer | $103,846 | $1,246,752 |
| 2024 | Outlook Therapeutics, Inc. (OTLK) | Former President and Chief Executive Officer | $600,000 | $6,377,953 |
| 2023 | Outlook Therapeutics, Inc. (OTLK) | President and Chief Executive Officer | $600,000 | $1,758,862 |
| 2022 | Outlook Therapeutics, Inc. (OTLK) | President and Chief Executive Officer | $600,000 | $1,333,179 |
| 2021 | Outlook Therapeutics, Inc. (OTLK) | President and Chief Executive Officer | $145,384 | $7,455,612 |
| 2020 | Outlook Therapeutics, Inc. (OTLK) | President and Chief Executive Officer | — | — |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.